Abvc Biopharma, Inc.

ABVC·NASDAQ·$1.29Share Price as of 11/2·$19MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/12/26 10-QQ1 ended 03/31/2605/18/26 10-KFY 202503/03/26 10-Q/AQ3 ended 09/30/2503/03/26 10-QQ3 ended 09/30/2511/03/25

Disclosures

8-KCurrent report08/27/26 8-K/ACurrent report (amended)08/12/26 8-KCurrent report08/04/26 8-KCurrent report07/02/26 8-KCurrent report03/27/26

Prospectuses and Registrations

424B4Prospectus08/17/26 424B4Prospectus08/17/26 424B4Prospectus08/17/26 424B4Prospectus08/17/26 POS AMPost-effective amendment03/27/26

Proxies

DEF 14ADefinitive proxy09/29/26 PRER14APreliminary proxy (revised)09/11/26 PRER14APreliminary proxy (revised)08/25/26 PRER14APreliminary proxy (revised)08/12/26 PRE 14APreliminary proxy07/28/26

Ownership

SC 13G/ABeneficial ownership (amended)08/13/25 SC 13D/ABeneficial ownership (amended)07/15/25 SC 13DBeneficial ownership06/03/25 SC 13G/ABeneficial ownership (amended)02/14/25 SC 13G/ABeneficial ownership (amended)11/14/24

Other

NT 10-QLate filing notification (10-Q)05/15/26 EFFECTRequest for effectiveness05/20/25 EFFECTRequest for effectiveness05/20/25 NT 10-KLate filing notification (10-K)03/31/25 EFFECTRequest for effectiveness08/01/24